Neoplasm by Site — Trials

Neoplasm by Site — Trials · CancerIndex

Clinical trials

Registered studies

92,594 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 301–350 of 2,632 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07625644	BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)	recruiting	Phase 3	550	SystImmune Inc.INDUSTRY	14	Sep 17, 2026	clinicaltrials
NCT07778316	Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)(DeLLphi-315)	recruiting	Phase 3	400	AmgenINDUSTRY	5	Sep 17, 2026